Clinical Trial

Interference and Stability Evaluation of the Intelligent Fingerprinting Drug Screening System

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Prospective, open-label, double-dose, performance evaluation of interference effects and component stability of the Intelligent Fingerprinting Drug Screening System
Trial Details
NCT Number NCT07758907
Lead Sponsor Intelligent Bio Solutions Inc.
Collaborators: CenExel
Conditions Interference With Routine Analytical Tests, Stability of in Vitro Diagnostic Reagents, Illicit Drug Use
Enrollment 95 participants
Start Date 2026-06-15
Primary Completion 2026-08 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-08-11